Location History:
- San Francisco, CA (US) (2007)
- Barcelona, ES (2009)
Company Filing History:
1 out of 90 
1 out of 15,528 
Years Active: 2007-2009
Title: Albert Jordan: Innovator in HIV Research
Introduction
Albert Jordan is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of HIV research, holding two patents that focus on the identification and treatment of latent human immunodeficiency virus (HIV) infections. His work is crucial in advancing our understanding of HIV and developing potential therapies.
Latest Patents
Jordan's latest patents include a method for the identification of compounds capable of activating latent HIV. This invention provides isolated cells that integrate a transcription-competent immunodeficiency virus into their genome. Under basal in vitro culture conditions, the virus remains latent, but its expression can be reactivated. The patent also outlines methods for creating subject cells and screening agents that can either activate or block the reactivation of latent HIV in response to T cell activation signals. Additionally, it offers methods for treating HIV infections.
Another patent focuses on cell lines with latent HIV, providing similar methodologies for identifying agents that can activate or inhibit the reactivation of the virus. These inventions are pivotal in the ongoing battle against HIV, offering new avenues for research and treatment.
Career Highlights
Throughout his career, Albert Jordan has worked with prestigious institutions, including the J. David Gladstone Institutes and the University of California. His research has been instrumental in the development of innovative approaches to HIV treatment and understanding the virus's behavior.
Collaborations
Jordan has collaborated with notable professionals in his field, including Eric M. Verdin. These partnerships have enhanced the impact of his research and contributed to the advancement of HIV studies.
Conclusion
Albert Jordan's contributions to HIV research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for new treatments and a deeper understanding of HIV.